Research Associate, Process Development (I,II,III)
TLDR
Support design and execution of experiments to advance the Cellares cell therapy production platform, contributing to scalable, automated manufacturing processes.
Under supervision of scientists, the candidate is expected to provide hands-on support to small-scale and scale-up experiments and overall development of the Cellares advanced cell therapy manufacturing platform
Support cell line maintenance and leukopak processing, including isolation, activation, gene modification, expansion and cryopreservation
Contribute to high-quality technical documents, procedures, reports
Contribute to analysis and presentation of technical results at departmental meetings
Support technology characterization experiments informing internal equipment and consumables performance evaluation
Perform routine laboratory activities including ordering and equipment qualification/maintenance
BS/MS or equivalent in Bioengineering, Chemical Engineering, Biology, Biochemistry, or related field
0-4 years of process development or cGMP manufacturing experience in the cell therapy or bioprocessing field
Hands-on experience in aseptic technique; experience in primary immune cell culture or bioreactors preferred
Hands-on experience with semi-automated instruments for cell therapy manufacturing
Strong problem-solving skills and attention to detail
Strong technical writing skills and experience authoring SOPs and reports
Creative, self-motivated, eager to take on a wide variety of tasks and grow with evolving technology
Self-awareness, integrity, authenticity, and a growth mindset
This is Cellares
Cellares is the first Integrated Development and Manufacturing Organization (IDMO) and takes an Industry 4.0 approach to mass manufacturing the living drugs of the 21st century. The company is both developing and operating integrated technologies for cell therapy manufacturing to accelerate access to life-saving cell therapies. The company’s Cell Shuttle integrates all the technologies required for the entire manufacturing process in a flexible and high-throughput platform that delivers true walk-away, end-to-end automation. Cell Shuttles will be deployed in Cellares’ Smart Factories around the world to meet total patient demand for cell therapies at global scale. Partnering with Cellares enables academics, biotechs, and pharma companies to accelerate drug development and scale out manufacturing, lower process failure rates, lower manufacturing costs, and meet global patient demand.
The company is headquartered in South San Francisco, California with its commercial-scale IDMO Smart Factory in Bridgewater, New Jersey. The company is backed by world-class investors and has raised over $355 million in financing.
Leveling will be based on overall experience, education, and demonstration of knowledge throughout the interview process.
Cellares is pioneering the field of cell therapy manufacturing as the first Integrated Development and Manufacturing Organization (IDMO) focused on harnessing Industry 4.0 technologies. Its innovative Cell Shuttle platform automates and integrates the entire production process, enabling companies in academia, biotechnology, and pharmaceuticals to accelerate the delivery of life-saving therapies while reducing costs and operational failures.